Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

Reducing Hospital Readmissions in Patients With Depressive Symptoms
Reducing Hospital Readmission Among Medical Patients With Depressive Symptoms
Status: Enrolling
Updated:  3/6/2018
Boston Med Ctr
2577
mi
from 91732
Boston, MA
Reducing Hospital Readmissions in Patients With Depressive Symptoms
Reducing Hospital Readmission Among Medical Patients With Depressive Symptoms
Status: Enrolling
Updated: 3/6/2018
Boston Med Ctr
2577
mi
from 91732
Boston, MA
Click here to add this to my saved trials
MoodHelper: Internet Cognitive Behavioral Therapy (CBT) for Depression
Internet CBT for Depression: Comparing Pure, Guided, and Stepped Care
Status: Enrolling
Updated:  3/6/2018
Kaiser Permanente Center for Health Research
829
mi
from 91732
Portland, OR
MoodHelper: Internet Cognitive Behavioral Therapy (CBT) for Depression
Internet CBT for Depression: Comparing Pure, Guided, and Stepped Care
Status: Enrolling
Updated: 3/6/2018
Kaiser Permanente Center for Health Research
829
mi
from 91732
Portland, OR
Click here to add this to my saved trials
Uridine Adolescent Bipolar Depression Randomized Controlled Trial
Placebo-Controlled Study of Uridine for Adolescent Bipolar Depression: a Magnetic Resonance Spectroscopy Study
Status: Enrolling
Updated:  3/7/2018
University of Utah
572
mi
from 91732
Salt Lake City, UT
Uridine Adolescent Bipolar Depression Randomized Controlled Trial
Placebo-Controlled Study of Uridine for Adolescent Bipolar Depression: a Magnetic Resonance Spectroscopy Study
Status: Enrolling
Updated: 3/7/2018
University of Utah
572
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
Thrive Care: Internet CBT for Depression
The Thrive Care Study: Computer-Delivered Cognitive Behavioral Therapy as Care Augmentation for Depressed Primary Care Patients
Status: Enrolling
Updated:  3/7/2018
Kaiser Fontana Medical Center
33
mi
from 91732
Fontana, CA
Thrive Care: Internet CBT for Depression
The Thrive Care Study: Computer-Delivered Cognitive Behavioral Therapy as Care Augmentation for Depressed Primary Care Patients
Status: Enrolling
Updated: 3/7/2018
Kaiser Fontana Medical Center
33
mi
from 91732
Fontana, CA
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative site 096
420
mi
from 91732
Tucson, AZ
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative site 096
420
mi
from 91732
Tucson, AZ
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 018
1456
mi
from 91732
Little Rock, AR
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 018
1456
mi
from 91732
Little Rock, AR
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 018
1456
mi
from 91732
Little Rock, AR
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 018
1456
mi
from 91732
Little Rock, AR
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 012
14
mi
from 91732
Cerritos, CA
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 012
14
mi
from 91732
Cerritos, CA
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 026
22
mi
from 91732
Culver City, CA
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 026
22
mi
from 91732
Culver City, CA
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site #021
20
mi
from 91732
Garden Grove, CA
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site #021
20
mi
from 91732
Garden Grove, CA
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site #025
31
mi
from 91732
Newport Beach, CA
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site #025
31
mi
from 91732
Newport Beach, CA
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site
73
mi
from 91732
Oceanside, CA
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site
73
mi
from 91732
Oceanside, CA
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 008
49
mi
from 91732
Redlands, CA
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 008
49
mi
from 91732
Redlands, CA
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 008
49
mi
from 91732
Redlands, CA
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 008
49
mi
from 91732
Redlands, CA
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 007
101
mi
from 91732
San Diego, CA
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 007
101
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 007
101
mi
from 91732
San Diego, CA
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 007
101
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 011
62
mi
from 91732
Temecula, CA
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 011
62
mi
from 91732
Temecula, CA
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site
827
mi
from 91732
Denver, CO
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site
827
mi
from 91732
Denver, CO
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 037
2305
mi
from 91732
Coral Springs, FL
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 037
2305
mi
from 91732
Coral Springs, FL
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site #015
2209
mi
from 91732
Fort Myers, FL
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site #015
2209
mi
from 91732
Fort Myers, FL
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 055
2318
mi
from 91732
Hallandale Beach, FL
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 055
2318
mi
from 91732
Hallandale Beach, FL
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 1854
2315
mi
from 91732
Hialeah, FL
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 1854
2315
mi
from 91732
Hialeah, FL
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 1854
2315
mi
from 91732
Hialeah, FL
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 1854
2315
mi
from 91732
Hialeah, FL
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 074
2308
mi
from 91732
Lauderhill, FL
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 074
2308
mi
from 91732
Lauderhill, FL
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 15
2149
mi
from 91732
Leesburg, FL
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 15
2149
mi
from 91732
Leesburg, FL
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative site 067
2320
mi
from 91732
Miami, FL
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative site 067
2320
mi
from 91732
Miami, FL
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative site 067
2320
mi
from 91732
Miami, FL
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative site 067
2320
mi
from 91732
Miami, FL
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site #005
2319
mi
from 91732
North Miami, FL
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site #005
2319
mi
from 91732
North Miami, FL
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 085
2314
mi
from 91732
Oakland Park, FL
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 085
2314
mi
from 91732
Oakland Park, FL
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 061
2185
mi
from 91732
Orlando, FL
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 061
2185
mi
from 91732
Orlando, FL
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site #004
2318
mi
from 91732
South Miami, FL
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site #004
2318
mi
from 91732
South Miami, FL
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site
2133
mi
from 91732
Tampa, FL
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site
2133
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 059
2184
mi
from 91732
Winter Park, FL
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 059
2184
mi
from 91732
Winter Park, FL
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site
1917
mi
from 91732
Atlanta, GA
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site
1917
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site
1917
mi
from 91732
Atlanta, GA
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site
1917
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 1830
1907
mi
from 91732
Marietta, GA
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 1830
1907
mi
from 91732
Marietta, GA
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 066
1911
mi
from 91732
Smyrna, GA
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 066
1911
mi
from 91732
Smyrna, GA
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site
1727
mi
from 91732
Chicago, IL
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site
1727
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 011
1706
mi
from 91732
Hoffman Estates, IL
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 011
1706
mi
from 91732
Hoffman Estates, IL
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 032
1717
mi
from 91732
Libertyville, IL
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 032
1717
mi
from 91732
Libertyville, IL
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 014
1719
mi
from 91732
Maywood, IL
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 014
1719
mi
from 91732
Maywood, IL
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 023
1702
mi
from 91732
Naperville, IL
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 023
1702
mi
from 91732
Naperville, IL
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 010
1713
mi
from 91732
Oak Brook, IL
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 010
1713
mi
from 91732
Oak Brook, IL
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 068
1726
mi
from 91732
Skokie, IL
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 068
1726
mi
from 91732
Skokie, IL
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site
1793
mi
from 91732
Indianapolis, IN
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site
1793
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 042
1757
mi
from 91732
Lafayette, IN
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 042
1757
mi
from 91732
Lafayette, IN
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 004
1336
mi
from 91732
Overland Park, KA
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 004
1336
mi
from 91732
Overland Park, KA
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative site 030
1654
mi
from 91732
New Orleans, LA
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative site 030
1654
mi
from 91732
New Orleans, LA
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 049
2271
mi
from 91732
Gaithersburg, MD
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 049
2271
mi
from 91732
Gaithersburg, MD
Click here to add this to my saved trials
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 006
2272
mi
from 91732
Rockville, MD
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 006
2272
mi
from 91732
Rockville, MD
Click here to add this to my saved trials